The application of Gadopentate-Dimeneglumin has no impact on progression free and overall survival as well as renal function in patients with monoclonal plasma cell disorders if general precautions are taken - Hillengaß, Jens; Stoll, Johanna; Zechmann, Christian; Kunz, Christina; Wagner, Barbara; Heiß, Christiane; Sumkauskaite, Migle; Möhler, Thomas; Schlemmer, Heinz-Peter; Goldschmidt, Hartmut; Delorme, Stefan (European radiology, 2015)
Published online: 31 October 2014